Á¦Ç° Ư¼º
-
ºÎºÐÀûÀ¸·Î ¼öÈµÈ ÇÏÀ̵å·ÎÁ© Çü¼º
-
ÇÁ·ÎÇÊ·» ±Û¸®ÄÝ º¸À¯
-
µ¶Æ¯ÇÑ ¿ë±â, ´Ù¾çÇÑ ¿ë·®
Á¦Ç°ÀÇ ÀåÁ¡
Á©ÀÇ ºÎºÐÀûÀÎ ¼öÈ Çü¼ºÀÌ Á©ÀÌ °ÇÁ¶È¯°æ¿¡ ¼öºÐÀ» °ø±ÞÇÏ°í, ½ÀÀ± Ä¡À¯ ȯ°æÀ» Á¶¼ºÇÏ¸é¼ °è¼ÓÀûÀ¸·Î ½ÀÀ± ȯ°æÀ» ¹è°¡½ÃÄÑ ÁÝ´Ï´Ù.
Necrotic tissue debridment (±«»ç Á¶Á÷ Á¦°Å)
±«»çÁ¶Á÷À» Àç¼öȽÃÅ°°í, ºÎµå·´Áö¸¸ ºü¸£°í È¿°úÀûÀ¸·Î ±«»çÁ¶Á÷À» Á¦°ÅÇØÁÝ´Ï´Ù.
Sloughy tissue debridment (ºÎÀ°Á¶Á÷ Á¦°Å)
¼Õ»ó¿¡ ³ëÃâµÈ À°¾ÆÁ¶Á÷¿¡ ¼Õ»ó¾øÀÌ ºÎÀ°°ú »ïÃâ¹°À» Èí¼öÇØÁÝ´Ï´Ù.
Moist Wound environment (½ÀÀ± ȯ°æ Á¶¼º)
Á©Àº »óó Ç¥¸é¿¡ ½ÀÀ±µµ¸¦ Áõ°¡½ÃÅ°°í, °¡ÇÇ Çü¼ºÀ» ¸·¾ÆÁÖ¸ç
¼Õ»ó¿¡ ³ëÃâµÈ À°¾ÆÁ¶Á÷À» ½ÀÀ±ÇÏ°Ô À¯Áö½ÃÅ°°í, »óÇǼ¼Æ÷ÀÇ ÀÌÁÖ¸¦ ÃËÁø½ÃÄÑ ÀÌ»óÀûÀÎ ½ÀÀ± ȯ°æÀ» Á¶¼ºÇØÁÝ´Ï´Ù.
Conformable (À¯¿¬ÇÑ È¿°ú)
ºÎµå·´Áö¸¸ È¿°úÀûÀ¸·Î ¼¼ºÎ À°¾ÆÁ¶Á÷ÀÇ ¼Õ»óÀ» ¸·°í, ¿Ü»óÀ» ÁÙÀÔ´Ï´Ù.
Non-adherent (ºñÁ¡Âø¼º)
»óó¿¡ ´Þ¶óºÙÁö ¾Ê¾Æ »ý¸®Àû ½Ä¿°¼ö·Î ¼¼Á¤½Ã ½±°Ô Á¦°ÅµÇ¸ç
ȯÀÚ¿¡°Ô ºÒÇÊ¿äÇÑ ÅëÁõÀ» À¯¹ß½ÃÅ°Áö ¾Ê°í, ¼Õ»ó¿¡ ³ëÃâµÈ Á¶Á÷¿¡ ÇÇÇظ¦ ÁÖÁö¾Ê½À´Ï´Ù.
Clinical evidence (ÀÇÇÐÀû ÀÔÁõ)
±¤¹üÀ§ÇÑ ÀÇÇÐÀû ÀÚ·á¿¡ ±Ù°Å ¸ðµç ´Ü°èÀÇ »óó Ä¡À¯°úÁ¤¿¡ »ç¿ë°¡´ÉÇÕ´Ï´Ù.
Bacteria barrier (¹ÚÅ׸®¾Æ Â÷´ÜÈ¿°ú)
Á©Àº ÇÁ·ÎÇÊ·»±Û¸®ÄÝÀ» º¸À¯Çؼ ¹ÚÅ׸®¾Æ Â÷´ÜÈ¿°ú¸¦ °¡Áø´Ù.
¶ÇÇÑ ±Û¸®ÄÝÀº Á©À» °ÇÁ¶ÇÏÁö ¾Ê°Ô Çؼ, ½ÀÀ±Á¦·Î¼ÀÇ ¿ªÇÒÀ» ÇÏ¸ç °ü¸®°¡ ¿ëÀÌÇÏ°Ô ÇÑ´Ù.
Easy to use (Æí¸®ÇÑ »ç¿ë¹æ¹ý)
Applipack ÇüÅ·Π½±°Ô »óó¿¡ ¹Ù·Î Àû¿ëÇÒ ¼ö ÀÖ°í, ±¼°îÁø ºÎÀ§¿¡µµ »ç¿ëÀÌ Æí¸®ÇÏ´Ù.
Various product range (´Ù¾çÇÑ ¿ë·®)
´Ù¾çÇÑ ¿ë·®ÀÌ ÀÖ¾î »óó Å©±â¿¡ µû¶ó Á¶ÀýÇÏ¿© »ç¿ë°¡´ÉÇÏ°í, ³¶ºñ¸¦ ¸·¾Æ ºñ¿ë È¿À²ÀûÀÎ Á¦Ç°ÀÔ´Ï´Ù.
ÀûÀÀÁõ
¾è°Å³ª ±íÀº °³¹æ»óó, ¿åâ, ÇÏÁö±Ë¾ç, ¿Ü°úÀû »óó, ¾Ç¼º »óó, ³·Àº ´Ü°èÀÇ È»ó, µüÁö, ¿»ó, Àý»ó, ¶ÇÇÑ À°¾ÆÁ¶Á÷ÀÌ »ý¼ºµÇ´Â »ç° »óó
ÀÇÇÐÀû °üÂûÀÌ ÀÖÀ»½Ã °¨¿° »óó¿¡ »ç¿ëÇÒ ¼ö ÀÖ´Ù
¹ÝÀûÀÀÁõ ¹× ÁÖÀÇ»çÇ×
-
Á©À̳ª À¯»ç¼ººÐ¿¡ ¹Î°¨¼ºÀÌ ¾Ë·ÁÁø ȯÀÚ
-
¾à°£ ¹ú¾îÁø, ±íÀº »óó, Á©Á¦°Å°¡ ¾î·Á¿î °÷, ´«ºÎÀ§¿¡´Â À¯ÀÇÇؼ »ç¿ëÇØ¾ß ÇÑ´Ù.
-
Á©Àº ¿Ü¿ëÀ̸ç, °æ±¸¿ëÀ¸·Î »ç¿ëÇؼ´Â ¾È µÈ´Ù.
Product Availability
Code
|
Size
|
Q'ty /Carton
|
7308
|
8g
|
10°³
|
7311
|
15g
|
10°³
|
7313
|
25g
|
10°³
|
|
»ç¿ë¹ý
Step 1:
»óó ºÎÀ§¸¦ Àû¿ëÀü¿¡ Áغñ¸¦ ÇÕ´Ï´Ù.
ÀÌÂ÷ µå·¹½ÌÀ» Á¦°ÅÇÏ°í, »óó ºÎÀ§¸¦ ¼¿¶óÀÎÀ¸·Î ¼¼Ã´ÇÕ´Ï´Ù.
Step 2:
º¸È£ ¸¶°³¸¦ Á¦°ÅÇÕ´Ï´Ù.
Ç×±Õ Å»Áö¸éÀ¸·Î ÀÔ±¸ ºÎºÐÀ» ¼¼Ã´ÇÕ´Ï´Ù.
ÀÔ±¸ ºÎºÐÀ» ºÎ·¯¶ß·Á Á¦°ÅÇÕ´Ï´Ù.
Step 3:
»óó¿¡ ÀÎÆ®¶ó»çÀÌÆ®Á¦¸¦ µµÆ÷ÇÕ´Ï´Ù.
»óó Ç¥¸é¿¡ ºÎµå·´°Ô ´©¸£¸é¼ »óó¿¡ Àû¿ëÇÕ´Ï´Ù.
»óó¿¡ 5mm µÎ²²·Î Àû¿ëÇÕ´Ï´Ù.
Step 4:
ÀÌÂ÷µå·¹½ÌÀ¸·Î ´ÙÀ½°ú µå·¹½ÌÀ» Àû¿ëÇÕ´Ï´Ù.
±«»çÁ¶Á÷ - ¿É»çÀÌÆ® Ç÷º½ÃÇȽº,
ºÎÀ° Á¶Á÷ - ¾Ë·¹ºó + ¿É»çÀÌÆ® Ç÷º½ÃÇȽº
À°¾Æ Á¶Á÷ - ¾Ë·¹ºó + ¿É»çÀÌÆ® Ç÷º½ÃÇȽº
°¨¿° Á¶Á÷ - ¾×ƼÄÚÆ®
Step 5:
ÀÎÆ®¶ó»çÀÌÆ® Á©ÀÇ Á¦°Å
ÀÎÆ®¶ó»çÀÌÆ® Á©Àº ¼¿¶óÀÎÀ¸·Î Ç󱸴 ¹æ¹ýÀ¸·Î Á¦°ÅÇÕ´Ï´Ù.
±«»çÁ¶Á÷À̳ª ºÎÀ°Á¶Á÷ÀÇ °æ¿ì, Àû¾îµµ 3ÀÏ¿¡ Çѹø¾¿Àº µå·¹½Ì ±³È¯À» ÇؾßÇϸç À°¾ÆÁ¶Á÷ÀÇ °æ¿ì, ȤÀº µå·¹½ÌÀÇ ±³È¯Àº »óóÀÇ ÀÓ»óÀûÀÎ »óųª »ïÃâ¹°ÀÇ ¾ç¿¡
µû¶ó °áÁ¤µÈ´Ù.
ÀÓ»óÀÚ·á
Paper title: The efficacy of a hydrogel in the treatment of wounds with non viable tissue
Author: Flanagan M.
Reference: Journal of Woundcare June, Vol 4, NO 6, 1995, 264-267
Study abstract: Failure to debride or cleanse a wound which consists of non-viable tissue will delay wound healing, may lead to an increase in wound size and could predispose to clinical infection particularly by anaerobic organisms.
Autolysis is the natural process of wound debridement. During autolysis the non-viable tissue is separated from the viable tissue in the wound bed by enzymes and macrophage activity. Hydrogels have been shown to promote autolysis by providing a moist wound environment. They can both donate and absorb fluid and can therefore be used to manage exuding wounds which contain non-viable tissue. These products are also used to manage infected wounds which require conservative debridement.
The purpose of the study was to assess efficacy and handling of an amorphous hydrogel (a modified formulation of IntraSite* Gel) in the debridement of wounds containing non-viable tissue which were treated in the hospital or community.
Results show an overall reduction in non-viable tissue of median 75% over the study period of 21 days. (leg ulcers 60%, pressure sores 75%, others 83%).
The product was shown to be both easy to apply and remove with 94% of assessed applications problem-free and 92% of assessed product removals reported as easy, no difficulties.
A difference in duration of wear was observed between the home care and hospital environments (median wear-time community 2.1 days, hospital 0.9 days) probably as a result of differences in resource.
Amorphous hydrogels are indicated for the debridement of non-viable tissue across a wide range of wound types and conditions. Hydrogels form an essential option in treatment regimes for cleansing of sloughy and necrotic wounds.
Paper title: Managing sloughy pressure sores
Author: Colin D. et al
Reference: Journal of Woundcare, Vol 5; NO 10, 1996
Study abstract: This clinical investigation compares the performance of an amorphous hydrogel and a dextranomer paste in the management of sloughy pressure sores in the hospital environment. Specific parameters measured during the study were efficacy, safety, ease of handling and patient comfort. The clinical investigation was restricted to the debridement of sloughy non viable tissue only. The amorphous hydrogel and dextranomer paste performed to a similar standard in terms of debridement of non viable tissue. At day 21, however, the median reduction in wound area was 35% in the amorphous hydrogel group compared to 7% in the dextranomer paste group. The hydrogel had a greater impact in reducing wound area. This different was statistically significant and demonstrates that the amorphous hydrogel provides an environment that facilitates wound healing.
In all of the parameters assessed, the amorphous hydrogel was found to be superior to the dextranomer paste dressing.
|